Enzo Life Sciences Exendin-4 GLP-1 receptor agonist
Exendin-4 is a 39 aa polypeptide and incretin mimetic which was first isolated from Gila monster saliva. The synthetic form, Exenatide, is a glucagon like peptide-1 (GLP-1) agonist approved for the treatment of diabetes mellitus type II.
Research shows Exendin-4 is involved in glucose-dependent enhancement of insulin secretion, reduction of hyperglycemia, glucose-dependent suppression of inappropriately high glucagon secretion, slowing of gastric emptying and reduction of food intake, often with body weight reduction or blunting of weight gain.
Phone: 02 4575 0309
AdipoGen Life Sciences DYRK inhibitors
Leucettinibs provide research tools and potential leads for further optimisation towards...
GroPep Bioreagents IGF-1 Family Proteins
IGF-1 proteins are available in different sizes, and all GroPep Bioreagents are freeze-dried and...
LSBio PathPlus Neuroscience Antibodies
LSBio PathPlus Neuroscience Antibodies are suitable for immunohistochemistry (IHC) applications...
Learn More
I am interested in Enzo Life Sciences Exendin-4 GLP-1 receptor agonist.
Complete the form and a supplier representative will be in touch.
